Pennsylvania Medicaid and tirzepatide
Zepbound for weight loss: no. Not covered for overweight or obesity. Other medically accepted uses are covered with prior authorization, with steps through other GLP-1 drugs. Mounjaro for weight loss: no; for type 2 diabetes Pennsylvania Medicaid must cover it. Read from Pennsylvania Department of Human Services, Office of Medical Assistance Programs documents Nov 6, 2026.
In 2025 Pennsylvania Medicaid paid for 243,243 tirzepatide prescriptions (Zepbound, Mounjaro), 29% of its GLP-1 prescriptions and 3rd of the 50 states and DC. It reimbursed $252.5 million before rebates, $1,038 a prescription against $1,032 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Zepbound | 207,261 | $218.2 million | $1,053 |
| Mounjaro | 35,982 | $34.3 million | $955 |
Pennsylvania plans and prescribing rules
Independence Blue Cross (IBX). Independence Blue Cross stopped covering drugs prescribed solely for weight loss, GLP-1s included, on January 1, 2025 or at plan renewal. Members whose employer adds a weight loss benefit keep GLP-1 coverage.
Tirzepatide in the states around Pennsylvania
| State | Sell tirzepatide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Zepbound for weight loss |
|---|---|---|---|---|
| Pennsylvania | 17 | $69/moWellmedr | 243,243 | Medicaid Zepbound: No |
| Delaware | 17 | $69/moWellmedr | 15,771 | Medicaid Zepbound: Unclear |
| Maryland | 17 | $69/moWellmedr | 20,355 | Medicaid Zepbound: No |
| New Jersey | 17 | $69/moWellmedr | 44,265 | Medicaid Zepbound: Not covered (KFF) |
| New York | 17 | $69/moWellmedr | 218,875 | Medicaid Zepbound: No |
| Ohio | 17 | $69/moWellmedr | 28,185 | Medicaid Zepbound: Not confirmed |
| West Virginia | 16 | $69/moWellmedr | 2,257 | Medicaid Zepbound: No |



